Clinical Trial Tracker

Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke: A Randomized, Placebo-controlled, Double-blinded, Single Center Study

Cerebrolysin in Critically Ill Patients With Delirium

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Study of Healthy Aging and Physical Function With Elamipretide

Parent thymosin beta-4 (not TB-500): Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness

Effect of Tirzepatide on Markers of MASLD in Patients With Obesity

A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult Volunteers

Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2

A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity

Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)

BPC 157 for Acute Hamstring Muscle Strain Repair

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

GLP-1R Agonist Treatment for Opioid Use Disorder

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

GLP-1R Actions on Muscle and the Skeleton

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity

Semaglutide for Smoking Cessation in Patients With Diabetes

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study

Tirzepatide in MetALD

Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Reproductive Hormones During Sustained Administration of Kisspeptin

Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury

Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus

IBI3042 Study in Healthy Participants and Overweight or Obese Participants

A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Interventions for Chronic Weight Management in Adult Participants With Obesity or Overweight

Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

Topical GHK-Cu Gel for Acute Skin Wound Healing

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

Kisspeptin Administration Subcutaneously to Patients With IHH

The Efficacy and Safety of Adjuvant GLP-1 Receptor Agonist Therapy Following Metabolic Bariatric Surgery in Chinese Patients With Obesity: A Prospective, Monocentric, Stratified Randomized Controlled Trial

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of MOTS-c (a Mitochondrial-Derived Peptide) in Adults With Prediabetes and Overweight/Obesity

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus

CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy

Tirzepatide in Idiopathic Intracranial Hypertension Trial

Multi-Site Trial of Tirzepatide for Smoking Cessation

A Study of BGM0504 in Early T2DM With Obesity

Achieving Sustained Weight Control Via Exercise, Nutrition & Drugs (Mazdutide) (ASCEND- 1 Trial)

COMMETS- Combination MCI Metabolic Syndrome

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Short-term Mazdutide Plus Lifestyle Intervention Versus Placebo for Pre-hepatectomy Prehabilitation in Living Liver Donors With MASLD: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Clinical Trial in Patients With Barth Syndrome- 4TAZPower

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

Incretin Therapies in Obesity-related HFpEF

Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease

Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea

Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)

A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in Youth

A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity

A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma

CERebrolysin In CADASIL

A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity

A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity

A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight

A Study of a Novel Precision Medicine Approach For Obesity

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212)

Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion

Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1

Exploring Cerebrolysin in Late Thrombectomy for Stroke: Blood-brain Barrier Biomarkers and Imaging Insights

Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial

Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study

Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients

Imaging in Semaglutide Study

The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)

Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease

A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants

Effect of Mazdutide on Coronary Plaque Progression in Patients With Coronary Atherosclerosis and Overweight or Obesity: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial

AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes

Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide: A Multicenter, Prospective, Randomized Controlled Trial (IIT)

Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults

A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems

DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies

Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial

Parent thymosin beta-4 (not TB-500): Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction

Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy

Tirzepatide in the Treatment of Cannabis Use Disorder

Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation

Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial

AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)

Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation

Preoperative Semaglutide Prior to Radical Prostatectomy

Efficacy and Safety of Mazdutide Injection for the Treatment of Overweight Patients With Compensated Cirrhosis and Clinically Significant Portal Hypertension

QUAdruple Therapy With RASi, Empagliflozin, Finerenone, and Mazdutide in Type 2 Diabetes and Early Treatment of Nephropathy(QUARTET-DKD)

Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial

Efficacy and Safety of Mazdutide in Adults With Prediabetes: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial (DREAM-PRE)

GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD

Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients

Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss

PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses

Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy

Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity

Mazdutide Plus Levonorgestrel-Releasing Intrauterine System for Fertility-Sparing Treatment in Overweight or Obese Patients With Atypical Endometrial Hyperplasia or Early Endometrioid Endometrial Cancer

Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation

GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward

Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes

Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults

Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)

TH9507 in Patients With HIV-Associated Lipodystrophy

Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke

Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease

Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia

Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

Parent thymosin beta-4 (not TB-500): Study of Thymosin Beta 4 in Patients With Pressure Ulcers

Parent thymosin beta-4 (not TB-500): Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers

Ipamorelin for Postoperative Ileus

Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men

Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke

Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients

Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of Intravenous (IV) Infusion of MTP-131 (Bendavia™) in Healthy Adults

The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke

Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.

Parent thymosin beta-4 (not TB-500): Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye

SMART: Somatotrophics, Memory, and Aging Research Trial

Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese

Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia

The Impact of Intravenous Bendavia™ on Endothelial Reactivity Dysfunction in Cigarette Smoking

Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder

Effects of Short-term Growth Hormone in HIV-infected Patients

Parent thymosin beta-4 (not TB-500): Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye

A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)

Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days

Dose-Finding Study of Ipamorelin for Post-Surgical GI Recovery

Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy

KP-10 and Insulin Secretion in Men

Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke

Effects of Growth Hormone Releasing Hormone in HIV

Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys.

Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in Men

Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure

A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration

Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes

A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function

TB4-labelled scaffold (exact construct unverified; not evidence for Ac-LKKTETQ): Slow-release Tb4 Collagen and Chitosan Porous Sponge Scaffolds Skin Substitute Treatment is Difficult to Heal Wounds

Hair Repigmentation During Cerebrolysin Therapy

Phase 1 Study of ACE-083 in Healthy Subjects

Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling

Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy

Neuropeptides in Human Reproduction

1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

Parent thymosin beta-4 (not TB-500): Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1

A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly

2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

The Use of the Hormone Kisspeptin in 'in Vitro Fertilisation' (IVF) Treatment

Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study

A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction

Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis

Effect of Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Reduced Ejection Fraction

Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy

A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure

Parent thymosin beta-4 (not TB-500): Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2

An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration

Parent thymosin beta-4 (not TB-500): A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers

A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)

Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage

The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment

Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke

the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome

Cerebrolysin and Neurodevelopment in Preterm Infants

Tachykinin and Kisspeptin Expression in Human Granulosa and Cumulus Cells

Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran

Tesamorelin Effects on Liver Fat and Histology in HIV

A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants

Parent thymosin beta-4 (not TB-500): A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers

Kisspeptin in the Evaluation of Delayed Puberty

A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy

Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity

Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

A Study of LY3502970 in Healthy Participants

Induction of Antitumor Response in Melanoma Patients Using the Antimicrobial Peptide LL37

A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.

A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes

A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk

Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia

Parent thymosin beta-4 (not TB-500): Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3

A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome

Kisspeptin Administration in the Adult

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

Parent thymosin beta-4 (not TB-500): Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction

A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity

ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA

A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)

A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus

A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

A Study of LY3437943 in Participants With Type 2 Diabetes

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test

A Study of LY3437943 in Participants Who Have Obesity or Are Overweight

A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants

Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight

A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

Parent thymosin beta-4 (not TB-500): Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction

A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants

Administration of Kisspeptin in Patients With Hyperprolactinemia

A Study of LY3437943 in Chinese Participants With Obesity Or Overweight

Phase I: Safety and Efficacy of an Injectable Follistatin Plasmid Gene Therapy in Humans

A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons

A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants

A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906

A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices

Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea

A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.

A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease

Dampening the Reproductive Axis With Continuous Kisspeptin

Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese

A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants

A Study of LY3437943 in Healthy Participants With a High Body Mass Index

FRDA Investigator Initiated Study (IIS) With Elamipretide

A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities

Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities

Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)

The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)

A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

A Study of LY3437943 in Participants With Impaired and Normal Liver Function

A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity

To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants

A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body

Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU

A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight

A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes

A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease

A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943

Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders

Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism

A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body

A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk

Combined Active Treatment in Type 2 Diabetes With NASH

IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)

A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease

Effect of Tirzepatide on Brown Adipose Tissue in Obesity

A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease

A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

A Multicenter, Randomized, Open-label Phase 3 Study Comparing the Efficacy and Safety of IBI362 Versus Semaglutide in Chinese Participants With Early Type 2 Diabetes and Obesity (DREAMS-3)

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

Safety and Efficacy of Klotho and Follistatin Gene Therapy

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

A Phase 2, Double-Blind, Proof of Concept Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk

Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight

INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

Lifestyle Counseling and Medication for Adolescent Weight Management

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes

Spartina® (Tirzepatide) Effectiveness and Safety Evaluation

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction

A Study on How NNC0174-1213 Works in People With Overweight or Obesity.

A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy

A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight

Cerebrolysin and Recovery After Stroke (CARS)

Cerebrolysin and Recovery After Stroke 2 (CARS2)

Cerebrolysin Acute Stroke Treatment in Asia (CASTA)

Cerebrolysin in Vascular Dementia

Cerebrolysin in Moderate Alzheimer's Disease

E-CARS Extension Study

A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia

Glutathione in Cystic Fibrosis

IV Glutathione in Parkinson's Disease

Liposomal Glutathione in HIV

Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)

Parent thymosin beta-4 (not TB-500): A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds

Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448

Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting

Parent thymosin beta-4 (not TB-500): A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa

The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery

A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism

Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone

Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)

A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy Followed by Open-Label Extension

Parent thymosin beta-4 (not TB-500): Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1

Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease

Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX)

Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)

IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE

Recall by Genotype: Neuropeptide Stimulation

Body Composition and Adipose Tissue in HIV

A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity

Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects

Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue

A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

Parent thymosin beta-4 (not TB-500): A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers

Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia

Parent thymosin beta-4 (not TB-500): A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction

Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic Clamp

Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance

A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of PL 14736 in Healthy Male Subjects

Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral Palsy

Comprehensive Reparative Therapy in Ischemic Stroke COMplex Repair in Ischemic Stroke-Arm

The Efficacy of LL-37 Cream on Aerobic Bacteria Colonization Pattern, Inflammation Response: Interleukin 1α (IL-1α) and Tumor Necrosis Factor α (TNF-α), and Healing Rate of Diabetic Foot Ulcers

Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)

Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT

Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.

Effects of Cerebrolysin on Level of Consciousness and Brain Metabolism in Disorder of Consciousness After Stroke: Single Center Randomized Controlled Study

A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)

Cerebrolysin in Prevention of Postoperative Delirium in Cardiac Surgery

Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke

CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke

Free Fatty Acid Effects In Type 2 Diabetes

Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women

Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV

A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)

An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder